The consent process in clinical trials – more formally designated the Informed Consent process – is a key element in getting participants involved. Without a signed Informed Consent Form (ICF) the participant is not able to be enrolled in the trial.

Traditionally, this has been a paper form, which is why eConsent has become a big thing in the industry over the last few years – especially since Covid – with the arrival of many tech solutions providers who want to make the sign-up process easier.

But the key element of the phrase might actually be the word ‘process’, rather than the word ‘consent.’

Comprehensive information about the study and what participating will involve needs to be conveyed to the patient, in language they can understand, in order for them to make an informed decision about taking part.

And this shouldn’t be a one-off procedure, more an ongoing reaffirmation of consent as the trial progresses.

You may also like

Biotech C-suites Should keep Patient Recruitment in Mind from the Outset
In biotech, a strong C-suite isn’t just about job titles - it’s about covering every part of the journey from discovery to delivery. Including being prepared to tackle one of the biggest ...
Key C-suite Roles for Biotech Success - The Chief Patient Recruitment Officer (CPRO)
While biotech companies have built C-suites with scientific, medical, financial, operational, and business expertise, a critical function has remained conspicuously absent - addressing one ...
Key C-suite Roles for Biotech Success - The Chief Business Officer (CBO)
The Chief Business Officer leads external strategy - licensing deals, identifying pharma partnerships, and developing long-term growth planning and market positioning strategies that ...